<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/static/PubMed.dtd">
<ArticleSet><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Research in Medical Sciences</JournalTitle><Issn>1735-1995</Issn><Volume>16</Volume><Issue>8</Issue><PubDate PubStatus="epublish"><Year>2011</Year><Month>08</Month><Day>15</Day></PubDate></Journal><ArticleTitle>In vitro and in vivo activities of Peganum harmala extract against Leishmania major</ArticleTitle><FirstPage>6650</FirstPage><LastPage>6650</LastPage><Language>EN</Language><AuthorList><Author><FirstName>Parvaneh</FirstName><LastName>Rahimi-Moghaddam</LastName></Author><Author><FirstName>Soltan Ahmad</FirstName><LastName>Ebrahimi</LastName></Author><Author><FirstName>Hourmazd</FirstName><LastName>Ourmazdi</LastName></Author><Author><FirstName>Monavvar</FirstName><LastName>Selseleh</LastName></Author><Author><FirstName>Maryam</FirstName><LastName>Karjalian</LastName></Author><Author><FirstName>Giti</FirstName><LastName>Haj-Hassani</LastName></Author><Author><FirstName>Mohammad Hossein</FirstName><LastName>Alimohammadian</LastName></Author><Author><FirstName>Massoud</FirstName><LastName>Mahmoudian</LastName></Author><Author><FirstName>Massoumeh</FirstName><LastName>Shafiei</LastName><Affiliation>Associate Professor, Department of Pharmacology, Razi Institute for Drug Research, Medical School, Tehran University of Medical Sciences, Tehran, Iran. m-shafiei@tums.ac.ir</Affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2011</Year><Month>01</Month><Day>18</Day></PubDate><PubDate PubStatus="accepted"><Year>2011</Year><Month>05</Month><Day>31</Day></PubDate><PubDate PubStatus="revised"><Year>2011</Year><Month>07</Month><Day>03</Day></PubDate></History><Abstract>BACKGROUND: In vitro and in vivo antileishmanial activities of crude hydroalcoholic extract of peganum harmala seeds were investigated against Leishmania major. METHODS: The extract of&amp;nbsp; aerial parts of P harmala was obtained by maceration. The in vitro experiments were per- formed on promastigotes to assess antileishmanial activity of the extract using amphotericin B as a reference. The in vivo studies were carried out on cutaneous leishmaniasis in outbred mice to evaluate the effects of topical application of the ointment-based extract. RESULTS: The in vitro experiments showed a concentration-dependent decrease of parasites number caused by the ex- tract with an IC50 value of 59.4 g/ml. In vivo studies demonstrated a significant post-treatment decrease in the lesion size and parasite count in infected animals, compared to placebo and control groups. High performance liquid chroma- tography (HPLC) of the crude extract demonstrated the existence of harmaline and harmine as beta-carboline alkaloids. CONCLUSIONS: P harmala seeds extract showed significant in vitro and in vivo antileishmanial activities. Most biologi- cal activity of the extract could be attributed to&amp;nbsp; its beta-carboline content. However, another alkaloid of P harmala seeds extract, peganine, has also been reported to have antileishmanial activity. These beneficial effects can be attri- buted to the cumulative effects of various biologically active components present in it. KEYWORDS: Cutaneous leishmaniasis; Leishmania Major, Peganum Harmala; Outbred Mice.</Abstract></Article></ArticleSet>
